Nav 1: 14.614
Date : 21-Mar-2025
Average AUM : 79656.61
| Stock Name | Sector | Value Mn | % of Total Holdings | More Details |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | Pharmaceuticals | 187.5 | 10.98% | |
| ELI LILLY ORD SHS | Foreign equity | 119.1 | 6.97% | |
| Max Healthcare Institute | Hospital | 92.4 | 5.41% | |
| Cipla | Pharmaceuticals | 97.1 | 5.69% | |
| Apollo Hospitals Enterprises | Hospital | 86.3 | 5.05% | |
| Divis Laboratories | Pharmaceuticals | 86.8 | 5.08% | |
| Dr Reddys Laboratories | Pharmaceuticals | 78.4 | 4.59% | |
| Johnson & Johnson | Foreign equity | 68.6 | 4.02% | |
| Lupin | Pharmaceuticals | 60.2 | 3.53% | |
| AbbVie Inc | Foreign equity | 55.6 | 3.25% | |
| Fortis Healthcare | Hospital | 49.3 | 2.89% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 51.8 | 3.03% | |
| Laurus Labs | Pharmaceuticals | 44.2 | 2.59% | |
| Aurobindo Pharma | Pharmaceuticals | 35.1 | 2.06% | |
| Merck & Co Inc Shs | Foreign equity | 36.2 | 2.12% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 35.9 | 2.10% | |
| NOVARTIS AG | Foreign equity | 36.1 | 2.11% | |
| Mankind Pharma | Pharmaceuticals | 30.9 | 1.81% | |
| Alkem Laboratories | Pharmaceuticals | 29.9 | 1.75% | |
| Abbott Laboratories | Foreign equity | 30 | 1.76% | |
| Thermo Fisher Scientific Inc | Foreign equity | 30.2 | 1.77% | |
| Intuitive Surgical | Foreign equity | 28 | 1.64% | |
| Amgen | Foreign equity | 24.3 | 1.42% | |
| Biocon | Pharmaceuticals | 23.9 | 1.40% | |
| Ipca Laboratories | Pharmaceuticals | 22.5 | 1.32% | |
| Novo Nordisk A/S | Foreign equity | 22.6 | 1.32% | |
| Zydus Lifesciences | Pharmaceuticals | 20.9 | 1.22% | |
| Gilead Sciences | Foreign equity | 21 | 1.23% | |
| Danaher Corporation | Foreign equity | 20.3 | 1.19% | |
| Medtronic Plc | Foreign equity | 17 | 0.99% | |
| Stryker Corporation | Foreign equity | 16.7 | 0.98% | |
| Narayana Hrudayalaya | Hospital | 15.4 | 0.90% | |
| Vertex Pharmaceuticals | Foreign equity | 16 | 0.94% | |
| Gland Pharma | Pharmaceuticals | 14.5 | 0.85% | |
| Syngene International | Healthcare research, analytics & technology | 13.4 | 0.79% | |
| Piramal Pharma | Pharmaceuticals | 11.7 | 0.69% | |
| Ajanta Pharma | Pharmaceuticals | 13.8 | 0.81% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 11.9 | 0.70% | |
| Global Health | Hospital | 10.9 | 0.64% | |
| Regeneron Pharmaceuticals | Foreign equity | 11.1 | 0.65% | |
| Becton Dickinson and Co | Foreign equity | 7.7 | 0.45% | |
| Suven Pharmaceuticals | Pharmaceuticals | 7.4 | 0.00% | |
| Agilent Technologies Inc | Foreign equity | 5.3 | 0.31% | |
| Iqvia Holdings | Foreign equity | 5.3 | 0.31% | |
| ILLUMINA | Foreign equity | 2.8 | 0.16% | |
| Aster DM Healthcare | Hospital | 8 | 0.47% |